2 enrolling by invitation. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Enrolling by invitation 2 |
| Phase 2 | 1 | Enrolling by invitation 1 |
Follow Angina Pectoris: new trials by email Literature Review of Angina Pectoris trials Research Report on Angina Pectoris
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Personalized Evaluation of Susptected Myocardial Ischemia Clinical Likelihood (CL) Model-Based Diagnostic Strategy, Standard of care treatment - Chronic Coronary Syndrome, Angina Pectoris | Phase 3 | Enrolling by invitation | Gødstrup Hospital | 2000 | 2024-11-20 | 2025-12-19 |
| Efficacy of Endothelin Receptor Antagonism in Coronary Artery Spasm Endothelin Receptor Antagonist, Placebo control - Coronary Spasm | Phase 2 / Phase 3 | Enrolling by invitation | Radboud University Medical Center | 100 | 2024-11-11 | 2024-11-18 |
Angina Pectoris, Variant (1) · Arteriosclerosis (1) · Coronary Artery Disease (1) · Myocardial Ischemia (1)
Cardiovascular Diseases (2) · Chest Pain (2) · Heart Diseases (2) · Neurologic Manifestations (2) · Pain (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Vascular Diseases (2) · Angina, Unstable (1) · Arterial Occlusive Diseases (1) · Coronary Disease (1) · Myocardial Ischemia (1)
Bosentan (1) · Endothelin Receptor Antagonists (1)
Gødstrup Hospital (1) · Radboud University Medical Center (1)
Denmark (1) · Netherlands (1)